Works matching IS 11707690 AND DT 2024 AND VI 42 AND IP 9

Results: 8

Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 1029, doi. 10.1007/s40273-024-01409-4

By:

Sutton, Andrew J.;
Lupu, Daniel S.;
Bergin, Stephen P.;
Holland, Thomas L.;
McAdams, Staci A.;
Dadwal, Sanjeet S.;
Nguyen, Khoi;
Nolte, Frederick S.;
Tremblay, Gabriel;
Perkins, Bradley A.

Publication type:

Article

NICE Approaches to Expert Opinion Evidence in Highly Specialised Technologies: Time to Change? Evidence Assessment Group Perspective.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 913, doi. 10.1007/s40273-024-01405-8

By:

Moradi, Najmeh;
O'Connor, Nicole;
Thomson, Katie H.;
Shabaninejad, Hosein;
Sotire, Tumi;
Still, Madeleine;
Fernandez-Garcia, Cristina;
Wallace, Sheila A.;
Williams, Oleta;
Vale, Luke;
Sagoo, Gurdeep S.

Publication type:

Article

Estimating an EQ-5D-Y-3L Value Set for Brazil.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 1047, doi. 10.1007/s40273-024-01404-9

By:

Espirito Santo, Caique Melo;
Miyamoto, Gisela Cristiane;
Santos, Verônica Souza;
Ben, Ângela Jornada;
Finch, Aureliano Paolo;
Roudijk, Bram;
de Jesus-Moraleida, Fabianna Resende;
Stein, Airton Tetelbom;
Santos, Marisa;
Yamato, Tiê Parma

Publication type:

Article

Rapid Assessment of the Need for Evidence: Applying the Principles of Value of Information to Research Prioritisation.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 919, doi. 10.1007/s40273-024-01403-w

By:

Glynn, David;
Gc, Vijay S.;
Claxton, Karl;
Littlewood, Chris;
Rothery, Claire

Publication type:

Article

Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 1017, doi. 10.1007/s40273-024-01398-4

By:

Gao, Ni;
Dakin, Helen A.;
Holman, Rury R.;
Lim, Lee-Ling;
Leal, José;
Clarke, Philip

Publication type:

Article

Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 929, doi. 10.1007/s40273-024-01388-6

By:

de Jong, Lisa A.;
Li, Xinyu;
Emamipour, Sajad;
van der Werf, Sjoukje;
Postma, Maarten J.;
van Dijk, Peter R.;
Feenstra, Talitha L.

Publication type:

Article

A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health Technologies.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 1003, doi. 10.1007/s40273-024-01395-7

By:

Tappenden, Paul;
Hardiman, Orla;
Kwon, Sun-Hong;
Mon-Yee, Mon;
Galvin, Miriam;
McDermott, Christopher

Publication type:

Article

A Systematic Review of Modeling Approaches to Evaluate Treatments for Relapsed Refractory Multiple Myeloma: Critical Review and Considerations for Future Health Economic Models.

Published in:

PharmacoEconomics, 2024, v. 42, n. 9, p. 955, doi. 10.1007/s40273-024-01399-3

By:

Freitag, Andreas;
Sarri, Grammati;
Ta, An;
Gurskyte, Laura;
Cherepanov, Dasha;
Hernandez, Luis G.

Publication type:

Article